DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients
- PMID: 16682945
- DOI: 10.1038/sj.onc.1209647
DEP-1 protein tyrosine phosphatase inhibits proliferation and migration of colon carcinoma cells and is upregulated by protective nutrients
Abstract
The transmembrane protein-tyrosine phosphatase (PTP) DEP-1 (density-enhanced phosphatase) is a candidate tumor suppressor in the colon epithelium. We have explored the function of DEP-1 in colon epithelial cells by inducible re-expression in a DEP-1-deficient human colon cancer cell line. Density-enhanced phosphatase-1 re-expression led to profound inhibition of cell proliferation and cell migration, and was associated with cytoskeletal rearrangements. These effects were dependent on the PTP activity of DEP-1 as they were not observed with cells expressing the catalytically inactive DEP-1 C1239S variant. shRNA-mediated suppression of DEP-1 in a colon epithelial cell line with high endogenous DEP-1 levels enhanced proliferation, further supporting the antiproliferative function of DEP-1. Nutrients, which are considered to be chemoprotective with respect to colon cancer development, including butyrate, green tea and apple polyphenols, had the capacity to elevate transcription of endogenous DEP-1 mRNA and expression of DEP-1 protein. Upregulation of DEP-1 expression, and in turn inhibition of cell growth and migration may present a previously unrecognized mechanism of chemoprevention by nutrients.
Similar articles
-
17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.Anticancer Res. 2000 Jan-Feb;20(1A):11-9. Anticancer Res. 2000. PMID: 10769629
-
The protein-tyrosine phosphatase DEP-1 modulates growth factor-stimulated cell migration and cell-matrix adhesion.Oncogene. 2003 Jul 3;22(27):4175-85. doi: 10.1038/sj.onc.1206652. Oncogene. 2003. PMID: 12833140
-
Prostate cancer chemoprevention by green tea: in vitro and in vivo inhibition of testosterone-mediated induction of ornithine decarboxylase.Cancer Res. 1999 May 1;59(9):2115-20. Cancer Res. 1999. PMID: 10232597
-
PRL phosphatases as potential molecular targets in cancer.Mol Cancer Ther. 2005 Nov;4(11):1653-61. doi: 10.1158/1535-7163.MCT-05-0248. Mol Cancer Ther. 2005. PMID: 16275986 Review.
-
Strategies for colon cancer prevention.Ann N Y Acad Sci. 1995 Sep 30;768:170-9. doi: 10.1111/j.1749-6632.1995.tb12120.x. Ann N Y Acad Sci. 1995. PMID: 8526346 Review. No abstract available.
Cited by
-
Enhanced insulin signaling in density-enhanced phosphatase-1 (DEP-1) knockout mice.Mol Metab. 2015 Feb 12;4(4):325-36. doi: 10.1016/j.molmet.2015.02.001. eCollection 2015 Apr. Mol Metab. 2015. PMID: 25830095 Free PMC article.
-
Role of PTPRJ genotype in papillary thyroid carcinoma risk.Endocr Relat Cancer. 2010 Oct 29;17(4):1001-6. doi: 10.1677/ERC-10-0143. Print 2010 Dec. Endocr Relat Cancer. 2010. PMID: 20823296 Free PMC article.
-
Convergent functional genomics of oligodendrocyte differentiation identifies multiple autoinhibitory signaling circuits.Mol Cell Biol. 2009 Mar;29(6):1538-53. doi: 10.1128/MCB.01375-08. Epub 2009 Jan 12. Mol Cell Biol. 2009. PMID: 19139271 Free PMC article.
-
Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase.Proc Natl Acad Sci U S A. 2012 Feb 7;109(6):1985-90. doi: 10.1073/pnas.1106171109. Epub 2012 Jan 23. Proc Natl Acad Sci U S A. 2012. PMID: 22308318 Free PMC article.
-
CD148 Serves as a Prognostic Marker of Gastric Cancer and Hinders Tumor Progression by Dephosphorylating EGFR.J Cancer. 2020 Feb 19;11(9):2667-2678. doi: 10.7150/jca.40955. eCollection 2020. J Cancer. 2020. PMID: 32201537 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases